Blog
RSS FeedPosted by Michael Wonder on 20 Mar 2026
DUSC utilisation analysis public release documents (October 2025)
20 March 2026 - The utilisation analysis public release documents from the October 2025 DUSC meeting are now available. ...
Posted by Michael Wonder on 20 Mar 2026
Public summary documents (first time decisions not to recommend and deferrals) – November 2025 PBAC meeting
20 March 2026 - The Public Summary Documents (first time decisions not to recommend and deferrals) from the November 2025 PBAC ...
Posted by Michael Wonder on 12 Mar 2026
ICER releases draft evidence report on treatment for narcolepsy
12 March 2026 - Public comment period now open until 7 April 2026; requests to make oral comment during public ...
Posted by Michael Wonder on 06 Mar 2026
Public summary documents – November 2025 PBAC meeting
6 March 2026 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the November 2025 PBAC ...
Posted by Michael Wonder on 12 Feb 2026
ICER publishes final evidence report on medication for smoking cessation
12 February 2026 - Independent appraisal committee votes reflect a net health benefit for cytisinicline alone, but uncertainty when compared ...
Posted by Michael Wonder on 31 Dec 2025
PBS Expenditure and Prescriptions Report (2024-25)
22 December 2025 - The PBS Expenditure and Prescriptions Report 1 July 2024 to 30 June 2025 is now available. ...
Posted by Michael Wonder on 24 Dec 2025
Public Summary Documents – September 2025 PBAC meeting
24 December 2025 - The Public Summary Documents (positive recommendations) from the September 2025 PBAC meeting are now available. ...
Posted by Michael Wonder on 18 Dec 2025
Update from the PBAC (December 2025)
18 December 2025 - The final PBAC update for 2025 is now available. ...
Posted by Michael Wonder on 16 Dec 2025
ICER publishes final evidence report on treatments for obesity
16 December 2025 - Independent committee voted unanimously on the positive net health benefit of all three treatments; final report ...
Posted by Michael Wonder on 11 Dec 2025
ICER publishes evidence report on medication for smoking cessation
11 December 2025 - Cytisinicline is effective for smoking cessation; a 12 week course of cytisinicline would be cost effective ...
Posted by Michael Wonder on 11 Dec 2025
ICER releases draft evidence report on therapies for IgA nephropathy
10 December 2025 - Public comment period now open until 14 January 2026; Requests to make oral comment during public ...
Posted by Michael Wonder on 03 Dec 2025
DUSC utilisation analysis public release documents (June 2025)
3 December 2025 - The utilisation analysis public release documents from the June 2025 DUSC meeting are now available. ...
Posted by Michael Wonder on 14 Nov 2025
Public Summary Documents (first time decisions not to recommend and deferrals) – July 2025 PBAC meeting
14 November 2025 - The Public Summary Documents (first time decisions not to recommend and deferrals) from the July 2025 PBAC ...
Posted by Michael Wonder on 31 Oct 2025
Public Summary Documents – July 2025 PBAC meeting
31 October 2025 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the July 2025 PBAC ...
Posted by Michael Wonder on 31 Oct 2025
ICER publishes final evidence report on treatment for non-cystic fibrosis bronchiectasis
30 October 2025 - Independent appraisal committee voted unanimously on the positive net health benefit of brensocatib; but current pricing ...